These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 9776253

  • 1. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.
    Pass HI, Mew DJ, Carbone M, Donington JS, Baserga R, Steinberg SM.
    Dev Biol Stand; 1998; 94():321-8. PubMed ID: 9776253
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R, Walker CL, Resnicoff M, Steinberg SM.
    Cancer Res; 1996 Sep 01; 56(17):4044-8. PubMed ID: 8752177
    [Abstract] [Full Text] [Related]

  • 3. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
    Long L, Rubin R, Baserga R, Brodt P.
    Cancer Res; 1995 Mar 01; 55(5):1006-9. PubMed ID: 7866982
    [Abstract] [Full Text] [Related]

  • 4. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D, Saunders B, Fu L, Mao W, Nicosia SV.
    Cancer Res; 1999 Jul 01; 59(13):3264-70. PubMed ID: 10397275
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T.
    Cancer Res; 2000 Feb 01; 60(3):760-5. PubMed ID: 10676665
    [Abstract] [Full Text] [Related]

  • 6. SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma.
    Procopio A, Marinacci R, Marinetti MR, Strizzi L, Paludi D, Iezzi T, Tassi G, Casalini A, Modesti A.
    Dev Biol Stand; 1998 Feb 01; 94():361-7. PubMed ID: 9776257
    [Abstract] [Full Text] [Related]

  • 7. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 9. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
    Kuo WW, Liu CJ, Chen LM, Wu CH, Chu CH, Liu JY, Lu MC, Lin JA, Lee SD, Huang CY.
    Apoptosis; 2006 Jul 01; 11(7):1075-89. PubMed ID: 16699953
    [Abstract] [Full Text] [Related]

  • 10. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL, Yi L, Tan H, Gan SU, Ilan J.
    Cancer Gene Ther; 2000 Mar 01; 7(3):384-95. PubMed ID: 10766344
    [Abstract] [Full Text] [Related]

  • 11. [The effect of blocking insulin-like growth factor-1 (IGF-1)-receptor system on tendon cell proliferation].
    Xiang Z, Yang Z, Zhang C.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jan 01; 12(1):35-8. PubMed ID: 10374621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
    Hoang CD, Zhang X, Scott PD, Guillaume TJ, Maddaus MA, Yee D, Kratzke RA.
    Cancer Res; 2004 Oct 15; 64(20):7479-85. PubMed ID: 15492273
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y, Wang H, Zhao J, Ma J, Wei L, Wu S, Xie T, Shen F, Trojan J, Habib N, Anthony DD, Wu M, Guo Y.
    Cancer Gene Ther; 2000 Mar 15; 7(3):456-65. PubMed ID: 10766352
    [Abstract] [Full Text] [Related]

  • 15. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.
    Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R.
    Cancer Res; 1994 Apr 15; 54(8):2218-22. PubMed ID: 8174129
    [Abstract] [Full Text] [Related]

  • 16. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P.
    J Pathol; 2004 Jan 15; 202(1):50-9. PubMed ID: 14694521
    [Abstract] [Full Text] [Related]

  • 17. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM, Providence KM, Higgins PJ.
    Cell Motil Cytoskeleton; 2001 Mar 15; 48(3):163-74. PubMed ID: 11223948
    [Abstract] [Full Text] [Related]

  • 18. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
    Szpechcinski A, Trzos R, Jarocki P, Trojan LA, Oficjalska K, Junkiert A, Wei MX, Mazurek M, Czapiewska JL, Niklinski J, Kopiński P, Chyczewski L, Kasacka I, Trojan J.
    Rocz Akad Med Bialymst; 2004 Mar 15; 49 Suppl 1():98-104. PubMed ID: 15638388
    [Abstract] [Full Text] [Related]

  • 19. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S.
    Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.
    Mitsiades CS, Mitsiades N.
    Expert Rev Anticancer Ther; 2005 Jun 15; 5(3):487-99. PubMed ID: 16001956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.